Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma - Impact of HSC dose on engraftment, safety, and immune reconstitution

Author: Michallet M.   Philip T.   Philip I.   Godinot H.   Sebban C.   Salles G.   Thiebaut A.   Biron P.   Lopez F.   Mazars P.   Roubi N.   Leemhuis T.   Hanania E.   Reading C.   Fine G.   Atkinson K.   Juttner C.   Coiffier B.   Fiere D.   Archimbaud  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.28, Iss.7, 2000-07, pp. : 858-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content